Role of IL-17 in psoriasis and psoriatic arthritis (Q37987880)

26 August 2017

Role of IL-17 in psoriasis and psoriatic arthritis (English)

1 reference

26 August 2017

Siba P Raychaudhuri

1

1 reference

26 August 2017

1 April 2013

1 reference

Clinical Reviews in Allergy & Immunology

26 August 2017

1 reference

26 August 2017

44

1 reference

26 August 2017

2

1 reference

26 August 2017

183-193

1 reference

https://scigraph.springernature.com/pub.10.1007/s12016-012-8307-1

26 August 2017

0 references

cites work

The prevalence of psoriasis in the world

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Pathogenesis and clinical features of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Psoriasis: genetic associations and immune system changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Pathogenesis and therapy of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Molecular dissection of psoriasis: integrating genetics and biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Genetics of psoriasis and psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

HLA-Cw6 and HLA-DRB1*07 together are associated with less severe joint disease in psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Activating killer cell immunoglobulin-like receptor gene KIR2DS1 is associated with psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Dermal injection of immunocytes induces psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

FR255734, a humanized, Fc-Silent, Anti-CD28 antibody, improves psoriasis in the SCID mouse-psoriasis xenograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

An anti-IL-12p40 antibody down-regulates type 1 cytokines, chemokines, and IL-12/IL-23 in psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Immunopathogenesis of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Interleukin-12, interleukin-23, and psoriasis: current prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Development, cytokine profile and function of human interleukin 17-producing helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon gamma is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Th17 cells in human disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

The lineage decisions of helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Transforming growth factor-beta induces development of the T(H)17 lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Phenotypic and functional features of human Th17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Distinct regulation of interleukin-17 in human T helper lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

STAT3 regulates cytokine-mediated generation of inflammatory helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Stat3 and Stat4 direct development of IL-17-secreting Th cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

An overview of IL-17 function and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Identification of an interleukin 17F/17A heterodimer in activated human CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Genome-wide comparison between IL-17A- and IL-17F-induced effects in human rheumatoid arthritis synoviocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Evidence for ligand-independent multimerization of the IL-17 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Cutting edge: interleukin 17 signals through a heteromeric receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Three is better than one: pre-ligand receptor assembly in the regulation of TNF receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Ligand-induced conformational changes allosterically activate Toll-like receptor 9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Cutting edge: identification of a pre-ligand assembly domain (PLAD) and ligand binding site in the IL-17 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Soluble and transmembrane isoforms of novel interleukin-17 receptor-like protein by RNA splicing and expression in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Interleukin-17: a novel inflammatory cytokine that bridges innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Functional Cooperation between Interleukin-17 and Tumor Necrosis Factor-α Is Mediated by CCAAT/Enhancer-binding Protein Family Members

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Interleukin 17 induces cartilage collagen breakdown: novel synergistic effects in combination with proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Targeting the development and effector functions of TH17 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

HLA is a candidate region for psoriatic arthritis. evidence for excessive HLA sharing in sibling pairs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Psoriatic disease--from skin to bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Drug insight: anti-tumor-necrosis-factor therapy for ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Classification of the spondyloarthropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

IL-23 induces human osteoclastogenesis via IL-17 in vitro, and anti-IL-23 antibody attenuates collagen-induced arthritis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Scid mouse model of psoriasis: a unique tool for drug development of autoreactive T-cell and th-17 cell-mediated autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

IL-17 receptor and its functional significance in psoriatic arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8307-1

The combination of tumor necrosis factor alpha blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model

21 January 2018

1 reference

12 December 2020

Interleukin 17 (IL-17) induces collagenase-3 production in human osteoarthritic chondrocytes via AP-1 dependent activation: differential activation of AP-1 members by IL-17 and IL-1beta

1 reference

12 December 2020

Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17

1 reference

12 December 2020

Interleukin-17 enhances tumor necrosis factor alpha-induced synthesis of interleukins 1,6, and 8 in skin and synovial fibroblasts: a possible role as a "fine-tuning cytokine" in inflammation processes

1 reference

12 December 2020

IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages

1 reference

12 December 2020

Anti-CD4 monoclonal antibody treatment of moderate to severe psoriasis vulgaris: results of a pilot, multicenter, multiple-dose, placebo-controlled study

1 reference

12 December 2020

GATA-3 protects against severe joint inflammation and bone erosion and reduces differentiation of Th17 cells during experimental arthritis

1 reference

12 December 2020

A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses

1 reference

12 December 2020

An IL-17F/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment

1 reference

12 December 2020

HLA studies in psoriatic arthritis: current situation and future needs

1 reference

12 December 2020

Predominance of CD8+ T lymphocytes in psoriatic arthritis

1 reference

12 December 2020

Reduction of joint inflammation and bone erosion in rat adjuvant arthritis by treatment with interleukin-17 receptor IgG1 Fc fusion protein

1 reference

12 December 2020

Human IL-17: a novel cytokine derived from T cells

1 reference

12 December 2020

Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides

1 reference

12 December 2020

High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism

1 reference

12 December 2020

Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles

1 reference

12 December 2020

Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines.

1 reference

12 December 2020

Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice

1 reference

12 December 2020

Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins

1 reference

12 December 2020

Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses

1 reference

12 December 2020

IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state

1 reference

12 December 2020

Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium

1 reference

12 December 2020

Mechanism of joint sparing in a patient with unilateral psoriatic arthritis and a longstanding hemiplegia

1 reference

12 December 2020

Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta

1 reference

12 December 2020

Anti-TNFalpha therapy for rheumatoid arthritis: an update.

1 reference

12 December 2020

IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis

1 reference

12 December 2020

Potential role of the chemokine receptors CXCR3, CCR4, and the integrin alphaEbeta7 in the pathogenesis of psoriasis vulgaris

1 reference

12 December 2020

10.1007/S12016-012-8307-1

Identifiers

DOI

1 reference

release_4yqoca3tb5cofanwet5karqp7i

26 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4yqoca3tb5cofanwet5karqp7i

24 November 2022

mapped directly with Wikidata item

PubMed ID

22362575

1 reference

PubMed ID

22362575